Iris Isufi
Impact in
Papers in
- Oncology 32
- CAR-T cell therapy research 20
- Cancer Immunotherapy and Biomarkers 8
-
- Lymphoma Diagnosis and Treatment 30
- Co-authors
- Muhammad Wasif Saif (3 shared papers)Kristin Kaley (1 shared paper)Stuart Seropian (18 shared papers)Scott F. Huntington (11 shared papers)Clément E. Tagoe (1 shared paper)Frederick Lansigan (1 shared paper)Francine M. Foss (10 shared papers)Lohith Gowda (11 shared papers)
- Journals
- Blood (22 papers)Journal of Clinical Oncology (8 papers)HemaSphere (4 papers)Blood Advances (2 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Iris Isufi
54 papers receiving 543 citations
Peers
Comparison fields: 5 of 62
- Genetics 112
- Oncology 261
- Hematology 105
- Pathology and Forensic Medicine 140
- Immunology 130
Countries citing papers authored by Iris Isufi
This map shows the geographic impact of Iris Isufi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Isufi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Isufi more than expected).
Fields of papers citing papers by Iris Isufi
This network shows the impact of papers produced by Iris Isufi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Isufi. The network helps show where Iris Isufi may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Isufi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. | 2010 | 77 |
| 2 | 2007 | 56 | |
| 3 | 2018 | 44 | |
| 4 | 2010 | 40 | |
| 5 | 2022 | 38 | |
| 6 | 2020 | 26 | |
| 7 | 2020 | 26 | |
| 8 | 2021 | 21 | |
| 9 | 2015 | 19 | |
| 10 | 2020 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2019 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2017 | 9 | |
| 17 | 2024 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2022 | 6 |
About Iris Isufi
Iris Isufi is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Hematology, having authored 62 papers that have together received 550 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (24 papers), CAR-T cell therapy research (20 papers), Cancer Immunotherapy and Biomarkers (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Cutaneous lymphoproliferative disorders research (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Genetics (112 citations), Oncology (261 citations), Hematology (105 citations), Pathology and Forensic Medicine (140 citations) and Immunology (130 citations). Iris Isufi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Muhammad Wasif Saif, Kristin Kaley, Stuart Seropian, Scott F. Huntington, Clément E. Tagoe, Frederick Lansigan, Francine M. Foss, Lohith Gowda, Sarah Perreault and Li Zhou. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Blood Advances and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.